Colorectal Cancer, Diabetes And Survival: Epidemiological Insights.
M.M.J. Zanders, P.A.J. Vissers, H.R. Haak, L.V. van de Poll-Franse
Published 2014 · Medicine
Download PDFAnalyze on Scholarcy
Colorectal cancer (CRC) patients with pre-existing diabetes have significantly lower rates of overall survival compared with patients without diabetes. Against this backdrop, the American Diabetes Association and American Cancer Society in 2010 reviewed the scientific literature concerning diabetes and cancer. One of the key issues identified for further investigation was the need for a better understanding of whether diabetes influences cancer prognosis above and beyond the prognosis conferred by each disease state independently. Whether the worsened survival of CRC patients with diabetes could be explained by less favourable patient-, tumour- and treatment-related characteristics has also been evaluated in numerous recent studies. However, as most studies did not account for all the various potential confounders, such as cancer stage, comorbidities and body mass index (BMI) in their analyses, the current evidence for the association between diabetes and survival in CRC patients remains inconclusive. Nevertheless, based on multiple examples in the literature, the present review demonstrates that diabetes affects the presentation of CRC as well as its treatment and outcome, which may then result in lower overall rates of survival in patients with, compared to those without, diabetes.
This paper references
Association between physical activity and mortality in colorectal cancer: a meta-analysis of prospective cohort studies.
Youjin Je (2013)
Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?
Nancy L. Keating (2008)
Objective measurements of activity patterns in people with newly diagnosed Type 2 diabetes demonstrate a sedentary lifestyle.
Simon Lebech Cichosz (2013)
Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002.
Patrick W. Sullivan (2005)
vated HbA 1 c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer : a case - control study
DS Hershey (2008)
Diabetes alone should not be a reason for withholding adjuvant chemotherapy for stage III colon cancer
Maren A. van Waalwijk (2011)
Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
Chris R. Garrett (2012)
Prognostic Models With Competing Risks: Methods and Application to Coronary Risk Prediction
Marcel Wolbers (2009)
Cancer statistics, 2010.
Ahmedin Jemal (2010)
Diabetes mellitus and risk of colorectal cancer: a meta-analysis.
Susanna C. Larsson (2005)
Impact of comorbidity and healthcare utilization on colorectal cancer stage at diagnosis: literature review
Mark Corkum (2011)
Impact of body mass index on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort.
Peter T. Campbell (2012)
Association Between Colonic Screening, Subject Characteristics, and Stage of Colorectal Cancer
Laura De Fazio (2005)
Competing risks and the clinical community: irrelevance or ignorance?
Michael T. Koller (2012)
A Cohort Study of Metformin Exposure and Survival in Patients with Stage I–III Colorectal Cancer
Susan Spillane (2013)
The role of the surgeon in whether patients with lymph node-positive colon cancer see a medical oncologist.
Ruili Luo (2007)
Postoperative 30-day Mortality Following Surgical Resection for Colorectal Cancer in Veterans: Changes in the Right Direction
Jessica A. Davila (2005)
Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer
Andrew G Renehan (2012)
Perceived Impact of Cancer Treatment on Diabetes Self-Management
Denise Soltow Hershey (2012)
Mortality After Incident Cancer in People With and Without Type 2 Diabetes
Craig J Currie (2012)
The impact of comorbid chronic conditions on diabetes care.
John D. Piette (2006)
The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus.
Jin Ha Lee (2012)
Influences on pre-hospital delay in the diagnosis of colorectal cancer: a systematic review
Edwin Mitchell (2008)
Short- and long-term impact of body mass index on laparoscopic rectal cancer surgery.
Quentin Denost (2013)
Diabetes Mellitus Affects Response to Neoadjuvant Chemoradiotherapy in the Management of Rectal Cancer
Abigail S Caudle (2008)
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
Mary E. Charlson (1987)
Surgical Site Infections Following Colorectal Surgery in Patients with Diabetes: Association with Postoperative Hyperglycemia
Yarrow J. McConnell (2008)
Diabetes and cancer: a consensus report.
Edward L. Giovannucci (2010)
Therapy Insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer
Lisa C. Richardson (2005)
Diabetes Mellitus and the Incidence of Colorectal Cancer: An Updated Systematic Review and Meta-Analysis
Longying Deng (2012)
Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
Sharlene Gill (2004)
Colorectal Cancer Outcomes, Recurrence, and Complications in Persons With and Without Diabetes Mellitus: A Systematic Review and Meta-Analysis
Kelly B. Stein (2009)
Trends in colorectal cancer in the south of the Netherlands 1975–2007: Rectal cancer survival levels with colon cancer survival
Valery E P P Lemmens (2010)
Adjuvant chemotherapy in the elderly: whom to treat, what regimen?
Susan Burdette-Radoux (2006)
Diabetes, metformin use, and colorectal cancer survival in postmenopausal women.
Furha I. Cossor (2013)
Smoking and diabetes.
Debra L. Haire-Joshu (1999)
Body iron stores and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study
Jukka Montonen (2012)
Diabetes mellitus and subsite-specific colorectal cancer risks in the Iowa Women's Health Study.
Paul John Limburg (2005)
see a medical oncologist
NL Keating (2007)
Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis.
Bethany B. Barone (2008)
Diminishing differences in treatment between patients with colorectal cancer with and without diabetes: a population-based study.
Marjolein M. J. Zanders (2013)
Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study.
Anthony P Polednak (2006)
Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias
Jeffrey A. Johnson (2011)
Impact of diabetes on overall and cancer-specific mortality in colorectal cancer patients
Francesca Bella (2013)
Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease
Yu-Chung Huang (2010)
Predictors of Diabetes Self-Management in Older Adults Receiving Chemotherapy
Denise Soltow Hershey (2014)
Do cancer cells care if their host is hungry?
Michael N. Pollak (2009)
Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort.
Ahmed N Dehal (2012)
Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, Wolff AC, Brancati FL. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 2008 300(23):2754-64. PMID: 19088353
Pamela J. Goodwin (2009)
Tumor Subsite Location Within the Colon Is Prognostic for Survival After Colon Cancer Diagnosis
Charlie M Wray (2009)
Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer.
Ruili Luo (2006)
Does Diabetes Care Differ by Type of Chronic Comorbidity?
Sri Ram Pentakota (2012)
Diabetes mellitus and outcomes of colorectal cancer
Eivind Jullumstrø (2009)
Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer.
Jeffrey A. Meyerhardt (2007)
Impact of Diabetes on Oncologic Outcome of Colorectal Cancer Patients: Colon vs. Rectal Cancer
Justin Y. Jeon (2013)
Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer.
Theodore J. Iwashyna (2002)
The Impact of Body Mass Index and Physical Activity on Mortality among Patients with Colorectal Cancer in Queensland, Australia
Peter David Baade (2011)
Inaccuracies of death certificate information.
Flanders Wd (1992)
Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence
Jonathan Andrew Johnson (2012)
Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.
Anja Schienkiewitz (2006)
Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer
Sarah A. Little (2002)
The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer.
Cary P Gross (2007)
Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies
Ying Jiang (2011)
Type 2 diabetes mellitus and colorectal cancer: meta-analysis on sex-specific differences.
Heike U. Krämer (2012)
Impact of diabetes mellitus on outcomes in patients with colon cancer.
Jeffrey A. Meyerhardt (2003)
Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry.
Floortje Mols (2013)
Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies
Bruno H Stricker (2010)
Obesity and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in Delaware.
Sangeeta Kumari Gupta (2014)
Elevated HbA1c Is an Independent Predictor of Aggressive Clinical Behavior in Patients with Colorectal Cancer: A Case-Control Study
Ali A Siddiqui (2008)
Disease-specific mortality among stage I–III colorectal cancer patients with diabetes: a large population-based analysis
Lonneke V van de Poll-Franse (2012)
Postoperative Mortality in Cancer Patients With Preexisting Diabetes
Bethany B. Barone (2010)
The impact of under and over-recording of cancer on death certificates in a competing risks analysis: a simulation study.
Sally R. Hinchliffe (2013)
Factors associated with the occurrence of leaks in stapled rectal anastomoses: a review of 1,014 patients.
Andrea Vignali (1997)
Inaccuracies of death certificate information.
W Dana Flanders (1992)
Mediterranean Diet and Type 2 Diabetes Risk in the European Prospective Investigation Into Cancer and Nutrition (EPIC) Study
Dora Romaguera (2011)
The association of diabetes with colorectal cancer risk: the Multiethnic Cohort
Jianjun He (2010)
Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
Jeffrey A. Meyerhardt (2006)
Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers
Una Macleod (2009)
Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis.
Lonneke V van de Poll-Franse (2007)
Comorbidity and colorectal cancer according to subsite and stage: a population-based study.
Matteo De Marco (2000)
Post - operative mortality in cancer patients with preexisting diabetes : systematic review and meta - analysis
JA Davila (2010)
This paper is referenced by
Diabetes and cancer - a dangerous liaison?: The reciprocal impact of diabetes and cancer on outcomes with a special focus on drug effects
M.M.J. Zanders (2015)
Four targeted genes for predicting the prognosis of colorectal cancer: A bioinformatics analysis case
Qing-lai Bian (2019)
Influence and mechanism of miR-99a suppressing development of colorectal cancer (CRC) with diabetes mellitus (DM)
Peixuan Zhu (2019)
Mixture cure model for estimating short-term and long-term colorectal cancer survival
Farzaneh Amanpour (2019)
Influence of Hyperglycemia on Treatment Outcomes of Oral Cavity Squamous Cell Carcinoma.
Kuang-Hsu Lien (2020)
AZD 1480 , a JAK inhibitor , inhibits cell growth and survival of colorectal cancer via modulating the JAK 2 / STAT 3 signaling pathway
Shu-wei Wang (2014)
The association between diabetes/hyperglycemia and the prognosis of cervical cancer patients
Shu Chen (2017)
Impact of diabetes comorbidity on the efficacy and safety of FOLFOX first-line chemotherapy among patients with metastatic colorectal cancer: a pooled analysis of two phase-III studies
Omar Abdel-Rahman (2018)
History of Diabetes and Survival Outcome Among Participants 65 Years or Older in SWOG Clinical Trials.
Dawn L. Hershman (2017)
Pre-existing diabetes mellitus and all-cause mortality in cancer patients: a register-based study in Latvia
Ieva Strele (2018)
Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression
Cheng-Ann Winston Ng (2020)
Characteristics and prognosis of Japanese colorectal cancer patients: The BioBank Japan Project
Akiko Tamakoshi (2017)
Diabetes Is Associated With the Metastasis of Pancreatic Neuroendocrine Tumors
Zhiyao Fan (2020)
Endocrine Disruptors and Epigenetics
John D. Bowman (2017)
Association between metformin use after surgery for colorectal cancer and oncological outcomes: A nationwide register‐based study
Tina Fransgaard (2018)
Higher Expression of Proteins in IGF/IR Axes in Colorectal Cancer is Associated with Type 2 Diabetes Mellitus
Jing Ding (2016)
AGR2 silencing contributes to metformin-dependent sensitization of colorectal cancer cells to chemotherapy.
Andrea Martisova (2019)
AZD1480, a JAK inhibitor, inhibits cell growth and survival of colorectal cancer via modulating the JAK2/STAT3 signaling pathway.
Shu-wei Wang (2014)
Association between fasting serum glucose levels and incidence of colorectal cancer in Korean men: the Korean Cancer Prevention Study-II.
Hyun-Young Shin (2014)